All of these indicate that inhibition of palmitoylation and conformational change of STING, or promotion of nitro-alkylation could be potential target to treat SAVI, which reveal the importance of PTMs of STING in diseases. Here, STING1 is linked to STING-associated vasculopathy with onset in infancy.